SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trickle Portfolio

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who started this subject10/22/2001 5:01:41 PM
From: nigel bates   of 1784
 
UK Trickle minnow warns -

LONDON, Oct 22 (Reuters) - Shares in Britain's Genetix Group Plc (LSE: GTX.L - news) plunged over a third on Monday after the supplier of robotic gene research equipment said annual profits would be "significantly" below expectations due to deferred orders.
At 1410 GMT the shares were 37 percent, or 48-1/2 pence, lower at 81-1/2p.
"A number of customers have delayed purchasing decisions even where Genetix has been chosen as the preferred supplier," the firm said in a trading update.
"As a result, revenues for the second half of the year will be adversely affected and as a consequence, profit before tax for the full year will be significantly below market expectations," it added...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext